Fusogenix, a proprietary proto-lipid vehicle (PLV) for genetic medicines, enables the formulation of effective DNA vaccines that can be administered like the flu vaccine. Fusogenix is an effective delivery of DNA payload as it directly drives into cells for potent immune response. Meet the CEO of Entos Pharmaceuticals, Dr. John Lewis. His biotechnology company develops next generation nucleic acid medicines and they just announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections. Learn more: https://www.entospharma.com/ The 'Future of Health' series is in partnership with Health City, who has been advocating for better, new, forward thinking healthcare system in Canada. Connect with Health City to learn more: https://edmontonhealthcity.ca/ Twitter: https://twitter.com/Yeghealthcity SUBSCRIBE to our channel for more educational and informative videos. Connect with us on our socials to join the conversation: Twitter: https://twitter.com/AlbertaImpact LinkedIn: https://www.linkedin.com/in/bryce-lambert/?originalSubdomain=ca Facebook: https://www.facebook.com/Albertaimpact/ Instagram: https://www.instagram.com/albertaimpact/?hl=en #COVID-19 #FusogenixDNAVaccine #HealthCare #Talkshow
Question or comment?
Let us know and we’ll get back to you as soon as we can.
